Company Filing History:
Years Active: 2022
Title: Innovations of Yu-Shan Wei in Sleep Disorder Treatments
Introduction
Yu-Shan Wei is a notable inventor based in Tainan, Taiwan. She has made significant contributions to the field of sleep disorder treatments through her innovative research and patenting efforts. Her work focuses on improving sleep quality and addressing related health issues.
Latest Patents
Yu-Shan Wei holds a patent for the use of a novel strain known as ProGA28, which is deposited in the German Collection for Microorganisms and Cell Cultures (DSMZ) under the accession number DSM 33167 since May 28, 2019. This invention relates to the treatment and improvement of sleep disorders. The metabolites of ProGA28 have demonstrated the ability to enhance sleep quality, reduce the time spent in rapid eye movement sleep, decrease the time it takes to fall asleep, increase total sleep time, and improve the ratio of low waves during sleep. These benefits contribute to the treatment of sleep disorders and associated complications, such as anxiety and immune system diseases.
Career Highlights
Yu-Shan Wei is currently associated with Syngen Biotech Co., Ltd., where she continues her research and development in the field of biotechnology. Her innovative approach has positioned her as a key figure in the advancement of treatments for sleep disorders.
Collaborations
Yu-Shan Wei collaborates with esteemed colleagues, including Wei-Jen Chen and Bing-Huang Gau, who contribute to her research endeavors and help in the development of her innovative solutions.
Conclusion
Yu-Shan Wei's contributions to the treatment of sleep disorders through her patented invention highlight her role as a leading inventor in the field. Her work not only addresses critical health issues but also paves the way for future innovations in sleep medicine.